You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 23, June 17, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  JAMA Patient Page
 This Article
 •Full text
 •PDF
 •Spanish PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •JAMA Patient Page
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sepsis

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

When the human body is invaded by an infectious organism (such as a bacterium, fungus, or virus), it fights back with a number of defense systems, including activation of numerous immune cells and molecules that help trap and kill the organism. The battle between the infection and the body's defenses can escalate, and the defenses themselves can unfortunately damage or impair vital organ function. Sepsis is a broad term that describes the syndrome of the body trying to fight a potentially serious infection. Sepsis is termed severe sepsis when this battle leads to acute vital organ damage. For example, a patient trying to fight pneumonia develops severe sepsis if the pneumonia is complicated by damage to the brain, heart, liver, lungs, or kidneys. Ultimately, death occurs in 20% to 50% of those who have severe sepsis. The most profound form of severe sepsis is septic shock (sepsis associated with hypotension . . . [Full Text of this Article]

SIGNS AND SYMPTOMS

Carolyn J. Hildreth, MD, Writer; Cassio Lynm, MA, Illustrator; Richard M. Glass, MD, Editor



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial
Dinna N. Cruz, Massimo Antonelli, Roberto Fumagalli, Francesca Foltran, Nicola Brienza, Abele Donati, Vincenzo Malcangi, Flavia Petrini, Giada Volta, Franco M. Bobbio Pallavicini, Federica Rottoli, Francesco Giunta, and Claudio Ronco
JAMA. 2009;301(23):2445-2452.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.